Cynthia Porter

Ms. Cynthia Porter

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
JBJefferey Burgess
Jefferey Burgess
SBShawn Beitel
Shawn Beitel
MCMiriam M Calkins
Miriam M Calkins
MFMelissa A Furlong
Melissa A Furlong
PFPaola Louzado Feliciano
Paola Louzado Feliciano
JGJohn J Gulotta
John J Gulotta
Background: Firefighters are at an increased risk of cancer and other health conditions compared with the general population. However, the specific exposures and mechanisms contributing to these risks are not fully understood. This information is critical to formulate and test protective interventions. Objective: The purpose of the Fire Fighter Cancer Cohort Study (FFCCS) is to conduct community-engaged research with the fire service to advance the evaluation and reduction of firefighter exposures, along with understanding and mitigating effects leading to an increased risk of cancer and other health conditions. This involves establishing a long-term (>30 years) firefighter multicenter prospective cohort study. Methods: The structure of the FFCCS includes a fire service oversight and planning board to provide guidance and foster communication between researchers and fire organizations; a data coordinating center overseeing survey data collection and data management; an exposure assessment center working with quantitative exposure data to construct a firefighter job exposure matrix; and a biomarker analysis center, including a biorepository. Together, the centers evaluate the association between firefighter exposures and toxic health effects. Firefighter research liaisons are involved in all phases of the research. The FFCCS research design primarily uses a set of core and project-specific survey questions accompanied by a collection of biological samples (blood and urine) for the analysis of biomarkers of exposure and effect. Data and samples are collected upon entry into the study, with subsequent collection after eligible exposures, and at intervals (eg, 1-2 years) after enrollment. FFCCS data collection and analysis have been developed to evaluate unique exposures for specific firefighter groups; cancer risks; and end points in addition to cancer, such as reproductive outcomes. Recruitment is carried out with coordination from partnering fire departments and eligible participants, including active career and volunteer firefighters in the United States. Results: The FFCCS protocol development was first funded by the US Federal Emergency Management Agency in 2016, with enrollment beginning in February 2018. As of September 2024, >6200 participants from >275 departments across 31 states have enrolled, including recruit and incumbent firefighters. Biological samples have been analyzed for measures of exposure and effect. Specific groups enrolled in the FFCCS include career and volunteer structural firefighters, women firefighters, trainers, fire investigators, wildland firefighters, firefighters responding to wildland-urban interface fires, and airport firefighters. Peer-reviewed published results include measurement of exposures and the toxic effects of firefighting exposure. Whenever possible, research results are provided back to individual participants. Conclusions: The FFCCS is a unique, community-engaged, multicenter prospective cohort study focused on the fire service. Study results contribute to the evaluation of exposures, effects, and preventive interventions across multiple sectors of the US fire service, with broad implications nationally. International Registered Report Identifier (IRRID): DERR1-10.2196/70522

13 November 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JMJosephine Mak
Josephine Mak
SKSana Khan
Sana Khan
ABAmadea Britton
Amadea Britton
SRSpencer Rose
Spencer Rose
LGLisa Gwynn
Lisa Gwynn
KLKaren Lutrick
Karen Lutrick
While there is evidence that COVID-19 vaccination protects against development of post-COVID conditions (PCC) after severe infection data are limited on whether vaccination reduces the risk after cases of less-severe non-hospitalized COVID-19 disease with more recent SARS-CoV-2 variant viruses. This study assessed whether COVID-19 vaccination was protective against subsequent development of PCC in persons with predominantly mild initial infections during both Delta and Omicron variant predominance. This study utilized a case-control design, nested within the HEROES-RECOVER cohort. Participants aged ≥18 years with PCR-confirmed SARS-CoV-2 infection between 6/28/2021 and 9/14/2022 were surveyed for PCC, defined by symptoms lasting >1 month after initial infection Cases were participants self-reporting PCC and controls were participants that did not self-report PCC. The exposure was mRNA COVID-19 vaccination (2 or 3 monovalent doses) versus no COVID-19 vaccination. Logistic regression was used to compare the odds of PCC among vaccinated and unvaccinated persons; additional analyses evaluating PCC subtypes were also performed. A total of 936 participants with documented SARS-CoV-2 infection were included; of these 23.6% (221) reported PCC and 83.3% (779) were vaccinated. Participants who received a 3rd COVID-19 monovalent mRNA dose prior to infection had lower odds of PCC-related gastrointestinal, neurological, and other symptoms compared to unvaccinated participants (aOR: 0.37; 95% CI: 0.16-0.85; aOR: 0.56; 95% CI: 0.32-0.97; aOR:0.48; 95% CI: 0.25-0.91). COVID-19 vaccination protected against development of PCC among persons with mild infection during both Delta and Omicron variant predominance, supporting vaccination as an important tool for PCC prevention.

2 February 2024 in Vaccine
Verified
Journal Article
Open access
PRPatrick Rivers
Patrick Rivers
CPCynthia Porter
Cynthia Porter
LLLindsay B. LeClair
Lindsay B. LeClair
ZJZuha Jeddy
Zuha Jeddy
AFAshley L Fowlkes
Ashley L Fowlkes
KLKaren Lutrick
Karen Lutrick
Pediatric COVID-19 vaccine hesitancy and uptake is not well understood. Among parents of a prospective cohort of children aged 6 months-17 years, we assessed COVID-19 vaccine knowledge, attitudes, and practices (KAP), and uptake over 15 months. The PROTECT study collected sociodemographic characteristics of children at enrollment and COVID-19 vaccination data and parental KAPs quarterly. Univariable and multivariable logistic regression models were used to test the effect of KAPs on vaccine uptake; McNemar's test for paired samples was used to evaluate KAP change over time. A total of 2,837 children were enrolled, with more than half (61 %) vaccinated by October 2022. Positive parental beliefs about vaccine safety and effectiveness strongly predicted vaccine uptake among children aged 5-11 years (aOR 13.1, 95 % CI 8.5-20.4 and aOR 6.4, 95 % CI 4.3-9.6, respectively) and children aged 12+ years (aOR 7.0, 95 % CI 3.8-13.0 and aOR 8.9, 95 % CI 4.4-18.0). Compared to enrollment, at follow-up parents (of vaccinated and unvaccinated children) reported higher self-assessed vaccine knowledge, but more negative beliefs towards vaccine safety, effectiveness, and trust in government. Parents unlikely to vaccinate their children at enrollment reported more positive beliefs on vaccine knowledge, safety, and effectiveness at follow-up. The PROTECT cohort allows for an examination of factors driving vaccine uptake and how beliefs about COVID-19 and the COVID-19 vaccines change over time. Findings of the current analysis suggest that these beliefs change over time and policies aiming to increase vaccine uptake should focus on vaccine safety and effectiveness.

1 August 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
ZLZoe Lyski
Zoe Lyski
CPCynthia Porter
Cynthia Porter
JUJennifer L Uhrlaub
Jennifer L Uhrlaub
KEKate Ellingson
Kate Ellingson
ZJZuha Jeddy
Zuha Jeddy
KLKaren Lutrick
Karen Lutrick
The PROTECT study is a longitudinal cohort study initiated in July 2021 with weekly testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 4 states: Arizona, Florida, exas, and Utah. This study aims to examine vaccine-elicited antibody response against postvaccination SARS-CoV-2 infections. Children aged 5–11 years had serum collected 14–59 days after their second dose of monovalent Pfizer-BioNTech coronavirus disease 2019 messenger RNA vaccine. Vaccine-elicited antibodies were measured using the area under the curve (AUC) and end-point titer using enzyme-linked immunosorbent assay (receptor-binding domain [RBD] and S2) and surrogate neutralization assays against ancestral (WA1) and Omicron (BA.2). 79 vaccinated participants (33 [41.7%] female; median age, 8.8 years [standard deviation, 1.9 years]), 48 (60.8%) were from Tucson, Arizona; 64 (81.0%) were non-Hispanic white; 63 (80.8%) attended school in person; 68 (86.1%) did not have any chronic conditions; and 47 (59.5%) were infected after vaccination. Uninfected children had higher AUCs against WA1 (P = .009) and Omicron (P = .02). The geometric mean and surrogate neutralization titer above the limit of detection was 346.0 for WA1 and 39.7 for Omicron, an 8.7-fold decrease (P < .001). After adjustment of covariates in the WA1-specific model, we observed a 47% reduction in the odds of postvaccination infection for every standard deviation increase in RBD AUC (aOR, 0.53 [95% confidence interval, .29–.97) and a 69% reduction in the odds of infection for every 3-fold increase in RBD end titer (0.31 [.06–1.57]). Children with higher antibody levels experienced a lower incidence of postvaccination SARS-CoV-2 infection.

14 October 2025 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Open access
MFMelissa Furlong
Melissa Furlong
SBShawn Beitel
Shawn Beitel
RCReagan Conner
Reagan Conner
Jaclyn GoodrichJaclyn Goodrich
Jaclyn Goodrich
XDXinxin Ding
Xinxin Ding
JBJefferey Burgess
Jefferey Burgess
Objective: The study goal was to evaluate changes in serum proteins following firefighter exposure to the January 2025 Los Angeles area urban conflagrations. Methods: The serum proteome was evaluated in 42 firefighters enrolled in the Fire Fighter Cancer Cohort Study with blood specimens collected in 2024 and in January and February of 2025, an average of 8.6 days after their most recent response to the urban conflagrations. Results: Sixty proteins changed significantly from before to after exposure. These proteins were associated with nucleotide synthesis and repair, oxidative stress response, energy metabolism, and other mechanisms. Pathway analysis identified changes in metabolism and oxidative stress, immune and inflammatory responses, cellular barrier integrity and trafficking, and growth/cancer signaling. Conclusions: Response to the Los Angeles area urban conflagration was associated with a change in the serum proteome of firefighters.

19 January 2026 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Open access
RCReagan Conner
Reagan Conner
JHJames Hollister
James Hollister
KLKaren Lutrick
Karen Lutrick
SBShawn Beitel
Shawn Beitel
Floris WardenaarFloris Wardenaar
Floris Wardenaar
JBJefferey Burgess
Jefferey Burgess
Objective: To identify potential predictors of serum concentrations of per- and polyfluoroalkyl substances (PFAS) among a cohort of US firefighters. Methods: Serum PFAS concentrations were measured in 2056 US structural firefighters between July 2023 and October 2024. Data on demographics, lifestyle behaviors, occupational exposures, and fire agency policies were collected through individual and fire agency surveys and evaluated for associations with serum PFAS concentrations. Results: Plasma and/or blood donation, drinking water source, military service, post-fire on-scene decontamination, turnout gear storage and transportation, rank, using aqueous film-forming foam, and carpet in fire station living quarters were all significant predictors of at least one PFAS chemical ( P ≤ 0.05). Conclusions: Both individual and departmental predictors of serum PFAS concentrations were identified. These findings can help guide the selection of PFAS exposure reduction activities by firefighters.